11-5225671-G-T
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM1PM2
The NM_000518.5(HBB):c.371C>A(p.Thr124Asn) variant causes a missense change. The variant allele was found at a frequency of 0.000013 in 1,613,884 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T124I) has been classified as Uncertain significance.
Frequency
Consequence
NM_000518.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
HBB | NM_000518.5 | c.371C>A | p.Thr124Asn | missense_variant | 3/3 | ENST00000335295.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
HBB | ENST00000335295.4 | c.371C>A | p.Thr124Asn | missense_variant | 3/3 | 1 | NM_000518.5 | P1 | |
HBB | ENST00000647020.1 | c.371C>A | p.Thr124Asn | missense_variant | 3/3 | P1 | |||
HBB | ENST00000475226.1 | n.303C>A | non_coding_transcript_exon_variant | 2/2 | 2 | ||||
HBB | ENST00000633227.1 | c.*187C>A | 3_prime_UTR_variant, NMD_transcript_variant | 3/3 | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152146Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00000796 AC: 2AN: 251294Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135814
GnomAD4 exome AF: 0.0000130 AC: 19AN: 1461738Hom.: 0 Cov.: 31 AF XY: 0.0000193 AC XY: 14AN XY: 727190
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152146Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74342
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jan 31, 2024 | Variant summary: HBB c.371C>A (p.Thr124Asn) results in a non-conservative amino acid change located in the Globin domain (IPR000971) of the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 8e-06 in 251294 control chromosomes (gnomAD). The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.371C>A (also known in the literature as Hb Ernz) has been reported in one polycythemic individual but it was also reported in two of his daughters who displayed normal RBC parameters (Groff_2000). Furthermore, the variant was detected in compound heterozygosity with Hb S in 3 siblings that were clinically and hematologically normal, with the authors concluding that it is a silent Hb variant not causing any pathology (Gunesacar_2012). In addition, c.371C>A was detected in an Italian child compound heterozygous for a pathogenic variant (c.118C>T, p.Gln40X) with clinical presentation similar to a beta thal trait (HbVar database) as well as an individual homozygous for Hb Ernz with borderline hematological parameters and a co-occurring 3.7kb deletion of the alpha-globin gene cluster (e.g., Shojaei_2024). Multiple other studies have reported the variant in carrier individuals (e.g. Giambona_2008, Alibakhshi_2019, Arpaci_2021). In several of these publications, the authors suggest the variant represents a benign/neutral polymorphism (e.g., Groff_2000, Gunesacar_2012, Fouladi_2007, Shojaei_2024). To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 31096791, 33851260, 32126744, 18603555, 11186258, 37826942). ClinVar contains an entry for this variant (Variation ID: 15584). Based on the evidence outlined above, the variant was classified as VUS-possibly benign. - |
beta Thalassemia Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 14, 2021 | - - |
alpha Thalassemia;C0002895:Hb SS disease;C0019025:Hereditary persistence of fetal hemoglobin;C0700299:Heinz body anemia;C1840779:METHEMOGLOBINEMIA, BETA TYPE;C1858990:Dominant beta-thalassemia;C1970028:Malaria, susceptibility to;C4693822:Erythrocytosis, familial, 6;CN322236:Beta-thalassemia HBB/LCRB Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Apr 08, 2022 | - - |
HEMOGLOBIN ERNZ Other:1
other, no assertion criteria provided | literature only | OMIM | Dec 12, 2017 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at